1. Home
  2. FBK vs HAE Comparison

FBK vs HAE Comparison

Compare FBK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$56.68

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$76.19

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBK
HAE
Founded
1906
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
FBK
HAE
Price
$56.68
$76.19
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$64.50
$84.13
AVG Volume (30 Days)
361.9K
871.5K
Earning Date
04-13-2026
05-07-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
N/A
EPS
1.10
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$41.72
N/A
Revenue Next Year
$7.21
$5.23
P/E Ratio
$51.11
$36.59
Revenue Growth
N/A
N/A
52 Week Low
$45.58
$47.32
52 Week High
$62.37
$87.32

Technical Indicators

Market Signals
Indicator
FBK
HAE
Relative Strength Index (RSI) 60.96 60.56
Support Level $56.78 $72.04
Resistance Level $60.20 $80.90
Average True Range (ATR) 0.93 2.68
MACD 0.11 -0.51
Stochastic Oscillator 89.49 54.12

Price Performance

Historical Comparison
FBK
HAE

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: